Literature DB >> 14525948

Abnormal PTEN expression in portal hypertensive gastric mucosa: a key to impaired PI 3-kinase/Akt activation and delayed injury healing?

Kouji Tsugawa1, Michael K Jones, Tomohiko Akahoshi, Woo Sung Moon, Yoshihiko Maehara, Makoto Hashizume, I James Sarfeh, Andrzej S Tarnawski.   

Abstract

Phosphatase and tensin homologue deleted on chromosome ten (PTEN) is a dual-specificity phosphatase that has activity toward both phosphorylated peptides and phospholipids. PTEN inhibits activation of Akt, the downstream effector of PI 3-kinase, which is integral to cell proliferation, migration, survival, and angiogenesis essential for tissue injury healing. PTEN expression and activation during injury healing remain unexplored. Portal hypertensive (PHT) gastric mucosa has impaired injury healing, but the underlying mechanisms remain unknown. We investigated whether impaired healing of injured PHT gastric mucosa is due to abnormal PTEN expression/activation that leads to decreased Akt activation. We also investigated the possible involvement of Egr-1, which regulates PTEN in some cells (e.g., fetal kidney epithelial cells), and TNF-alpha, which can induce Egr-1 expression. In PHT gastric mucosa 6 h after injury, PTEN protein levels were increased by 2.7-fold; unphosphorylated PTEN (reflecting activated PTEN) was increased by 2.4-fold; Akt phosphorylation (reflecting Akt activation) was reduced by 2-fold; and Egr-1 expression was increased by 3.3-fold vs. normal gastric mucosa. TNF-alpha neutralization reversed all of the above abnormalities in PHT gastric mucosa, reduced mucosal injury, and enhanced healing. We conclude that, in injured PHT gastric mucosa, overexpressed/activated PTEN leads to the reduced activation of the PI 3-kinase/Akt pathway that results in impaired injury healing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14525948     DOI: 10.1096/fj.02-1107fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  7 in total

1.  PTEN inhibition improves wound healing in lung epithelia through changes in cellular mechanics that enhance migration.

Authors:  Cosmin Mihai; Shengying Bao; Ju-Ping Lai; Samir N Ghadiali; Daren L Knoell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-28       Impact factor: 5.464

Review 2.  The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.

Authors:  V Baron; E D Adamson; A Calogero; G Ragona; D Mercola
Journal:  Cancer Gene Ther       Date:  2006-02       Impact factor: 5.987

3.  Identification of functional domains in AKT responsible for distinct roles of AKT isoforms in pressure-stimulated cancer cell adhesion.

Authors:  Shouye Wang; Marc D Basson
Journal:  Exp Cell Res       Date:  2007-08-16       Impact factor: 3.905

4.  PTEN: a promising pharmacological target to enhance epithelial wound healing.

Authors:  M Zhao
Journal:  Br J Pharmacol       Date:  2007-10-08       Impact factor: 8.739

5.  Inhibition of the phosphatase PTEN protects mice against oleic acid-induced acute lung injury.

Authors:  Ju-Ping Lai; Shengying Bao; Ian C Davis; Daren L Knoell
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

6.  Telomerase activity promotes osteoblast differentiation by modulating IGF-signaling pathway.

Authors:  Hamid Saeed; Weimin Qiu; Chen Li; Allan Flyvbjerg; Basem M Abdallah; Moustapha Kassem
Journal:  Biogerontology       Date:  2015-08-11       Impact factor: 4.277

Review 7.  PTEN Inhibition in Human Disease Therapy.

Authors:  Rafael Pulido
Journal:  Molecules       Date:  2018-01-30       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.